Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemonaive”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Testing effectiveness (Phase 2)UnknownNCT03823625
What this trial is testing

An Open-label, Randomized, Parallel, Non Comparative, Phase II Trial of Nivolumab Plus Ipilimumab Versus Platinum-based Chemotherapy Plus Nivolumab in Chemonaive Metastatic or Recurrent Squamous-Cell Lung Cancer (SqLC)

Who this might be right for
Squamous-Cell Lung Cancer
Fondazione Ricerca Traslazionale 112
Testing effectiveness (Phase 2)Study completedNCT00856830
What this trial is testing

Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerExtensive Stage Lung CancerChemonaive
University of Alabama at Birmingham 30
Testing effectiveness (Phase 2)Study completedNCT00432315
What this trial is testing

Docetaxel in Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Squamous Cell
Sanofi 80
Large-scale testing (Phase 3)UnknownNCT00005869
What this trial is testing

Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT00256711
What this trial is testing

Phase II Iressa Versus Vinorelbine (INVITE)

Who this might be right for
Non-Small-Cell Lung Carcinoma
AstraZeneca 192
Testing effectiveness (Phase 2)Ended earlyNCT00538681
What this trial is testing

Study for Participants With Advanced, Not Amenable to Surgery, or Metastatic Lung Cancer Comparing Treatment With Pemetrexed + Cisplatin + Enzastaurin Versus Pemetrexed + Cisplatin + Placebo

Who this might be right for
Lung Cancer
Eli Lilly and Company 35
Early research (Phase 1)Ended earlyNCT01409174
What this trial is testing

IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT00316186
What this trial is testing

First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin

Who this might be right for
Lung Cancer, Small Cell
GlaxoSmithKline 33
Testing effectiveness (Phase 2)UnknownNCT01042522
What this trial is testing

Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors

Who this might be right for
Ovarian Granulosa Cell TumorOvarian GynandroblastomaOvarian Sertoli-Leydig Cell Tumor+4 more
GOG Foundation 63
Testing effectiveness (Phase 2)Study completedNCT00173875
What this trial is testing

Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
National Taiwan University Hospital 108
Large-scale testing (Phase 3)Ended earlyNCT00558636
What this trial is testing

A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Bayer 91
Testing effectiveness (Phase 2)UnknownNCT00722969
What this trial is testing

Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Universitair Ziekenhuis Brussel 48
Testing effectiveness (Phase 2)Study completedNCT00675545
What this trial is testing

A Phase II Study of Docetaxel Plus Carboplatin in Chemonaive Hormone-Refractory Prostate Cancer (HRPC) Patients

Who this might be right for
Hormone-Refractory Prostate Cancer
National University Hospital, Singapore 2
Testing effectiveness (Phase 2)Study completedNCT00172380
What this trial is testing

Phase II Study of Docetaxel Plus CDDP for NSCLC Stage III

Who this might be right for
NSCLC
National Taiwan University Hospital 41
Large-scale testing (Phase 3)Ended earlyNCT00113256
What this trial is testing

Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Astex Pharmaceuticals, Inc. 39
Testing effectiveness (Phase 2)Study completedNCT00212043
What this trial is testing

Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma

Who this might be right for
Non Small Cell Lung Cancer
National University Hospital, Singapore 74
Testing effectiveness (Phase 2)Active Not RecruitingNCT01064648
What this trial is testing

Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Epithelioid MesotheliomaPleural Malignant MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 117
Not applicableEnded earlyNCT02221245
What this trial is testing

Wnt, Notch and Hedgehog Activity in Chemo-Naive Tumors Collected During Staging of Esophageal Cancer Patients

Who this might be right for
Esophageal Cancer
University of Miami 24
Testing effectiveness (Phase 2)UnknownNCT01377025
What this trial is testing

Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
Prof. Dr. med. Max. E. Scheulen 200
Large-scale testing (Phase 3)Ended earlyNCT00300885
What this trial is testing

Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small Cell Lung
Bayer 926
Load More Results